Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rishi G. Vaswani
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Related publications
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-Terminal Domain (BET) Proteins
Suppression of Interferon Β Gene Transcription by Inhibitors of Bromodomain and Extra-Terminal (BET) Family Members
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence
Therapeutic Advances in Hematology
Hematology
Preclinical Evaluation of the BET Bromodomain Inhibitor BAY 1238097 for the Treatment of Lymphoma
British Journal of Haematology
Hematology
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate
Bromodomain and Extra-Terminal Protein Inhibition Attenuates Neutrophil-Dominant Allergic Airway Disease
Scientific Reports
Multidisciplinary
Identification of Haptoglobin as a Natural Inhibitor of Trypanocidal Activity in Human Serum.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
BET Protein Bromodomain Inhibitor-Based Combinations Are Highly Active Against Post-Myeloproliferative Neoplasm Secondary AML Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
